Article
The myeloperoxidase -463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls.
Clinical biochemistry - 1 Nov 2013
Chang Cuixian, Gao Baorong, Liu Zheng, Mao Jianbin, Jiang Guoqiang
Abstract excerpt
OBJECTIVES: Genetic polymorphism of human myeloperoxidase (MPO) -463G/A has been implicated to alter the risk of coronary artery disease (CAD), but the results are controversial. To improve the reliability of the conflicting results, we conducted a meta-analysis of studies relating the MPO -463G/A polymorphism with the risk of CAD. DESIGN AND METHODS: Two investigators independently searched the MEDLINE, EMBASE...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
